Zeria Pharmaceutical Co., Ltd. Licenses Gastric Ulcer Drug To SK Chemicals Co. Ltd.
Published: Mar 03, 2006
Tokyo, Mar 2, 2006 (JCN) - ZERIA Pharmaceutical announced on March 2 that it had concluded a licensing agreement with Korean company SK Chemicals as of February 27. Under the terms of the agreement, SK Chemicals is licensed to develop and sell Promac Granules 15%, ZERIA's proprietary ethical agent for the treatment of gastric ulcers, exclusively in Korea.